← Leaderboards
Darby Thompson
The Emmes Company, Llc
$10,610,431
Attributed
$10,610,431
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.3M · FY2009–11$10M$7.5M$5M$2.5M$0
'09
'10
'11
Funding mix
By agency
NIH$10,610,431 · 1
By mechanism
N01$10,610,431 · 1
Top collaborators
No co-investigators on record.
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Keri Hammel$53,700,408
- Supriya Menezes$25,277,032
- Keri, Hammel$11,064,901
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorIntramural ResearchFollow-UpMedicareEpidemiologyHealthcareEye DiseasesExtramural ActivitiesEvaluationDesignContractorDatabasesEconomicsCase-Control StudiesArea AnalysesEarly TreatmentCost EffectivenessCollectionDiabetic RetinopathyClinical TrialsClinical ResearchData ManagementAcquired Immunodeficiency SyndromeNatural History
Grant awards (80)
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY$2,750,000
N01 · FY2011 · EY · contact PI
EyeGENE: Creation of DNA Repository for Inherited Ophthalmic Diseases$1,461,764
N01 · FY2010 · EY · contact PI
High Speed Angiography: Induction/PRN Regimen of Intravitreal Ranibizumab for AMD$172,878
N01 · FY2010 · EY · contact PI
Subconjunctival Sirolimus in the Treatment of AMD Bilateral Geographic Atrophy$135,595
N01 · FY2010 · EY · contact PI
Rituximab for Autoimmune Retinopathy$104,637
N01 · FY2010 · EY · contact PI
Optiquel as Corticosteroid-Sparing Therapy for Chronic Non-Infectious Autoimmune$84,711
N01 · FY2010 · EY · contact PI
Subconjunctival Sirolimus for Treatment of Autoimmune Active Anterior Uveitis$77,679
N01 · FY2010 · EY · contact PI
Study of Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema$73,406
N01 · FY2010 · EY · contact PI
Pilot: Sunitinib Malate for Advance Ocular Disease of Von Hippel-Lindau Syndrome$59,668
N01 · FY2010 · EY · contact PI
Microplasmin Intravitreal Administration in Patients with Uveitic Macular Edema$54,434
N01 · FY2010 · EY · contact PI
Intravitreal Inj of Ranibizumab for Macular Telangiectasia w/o Neovascularization$43,059
N01 · FY2010 · EY · contact PI
Intravitreal Inj of Ranibizumab for Macular Telangiectasia w Neovascularization$42,595
N01 · FY2010 · EY · contact PI
Pilot: Computer Administration of Vision Targeted Quality of Life Instruments$28,745
N01 · FY2010 · EY · contact PI
Evaluation of Single Nucleotide Polymorphisms (SNPs) in diabetic macular edema$12,165
N01 · FY2010 · EY · contact PI
A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 PUFA in AMD$10,306
N01 · FY2010 · EY · contact PI
Phase I Clinical Trial: Safety of Subconjunctival Cyclosporine Implant for GVHD$9,396
N01 · FY2010 · EY · contact PI
Genotype-Phenotype of Patients with Plaquenil )-Induced Retinal Toxicity (ABCA4)$7,480
N01 · FY2010 · EY · contact PI
Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema$7,030
N01 · FY2010 · EY · contact PI
Screening Study for the Evaluation and Diagnosis of Research Participants$6,566
N01 · FY2010 · EY · contact PI
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol$6,566
N01 · FY2010 · EY · contact PI
Immunopathology and Molecular Pathology of Ocular Diseases in Humans$6,566
N01 · FY2010 · EY · contact PI
Laboratory of Immunology/National Eye Institute Repository$6,566
N01 · FY2010 · EY · contact PI
Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease$6,566
N01 · FY2010 · EY · contact PI
Study of Association of Serum Factors with Diabetic Retinopathy$6,566
N01 · FY2010 · EY · contact PI
Evaluation and Treatment of Research Participants with Ocular Diseases$6,566
N01 · FY2010 · EY · contact PI
Evaluation of Single Nucleotide Polymorphism (SNP) in AMD Patients$6,566
N01 · FY2010 · EY · contact PI
Visual Motor Coordination$6,566
N01 · FY2010 · EY · contact PI
Age-Related Eye Disease Study (AREDS) Follow-Up$6,566
N01 · FY2010 · EY · contact PI
Epigenetics, Molecular Genetics, and Biomarkers of Inflammatory Ocular Diseases$6,566
N01 · FY2010 · EY · contact PI
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies$6,566
N01 · FY2010 · EY · contact PI
Family Studies of Uveal Coloboma$6,566
N01 · FY2010 · EY · contact PI
X Chr. Karyotype & Sex Hormones in Turner Syndrome & Premature Ovarian failure$6,566
N01 · FY2010 · EY · contact PI
Clinical and Molecular Studies in Families with Glaucoma$6,566
N01 · FY2010 · EY · contact PI
Clinical and Molecular Studies in Families with Myopia and Related Diseases$6,566
N01 · FY2010 · EY · contact PI
Molecular Genetics of Retinal Degenerations$6,566
N01 · FY2010 · EY · contact PI
Natural History and Genetic Studies of Usher Syndrome$6,566
N01 · FY2010 · EY · contact PI
Clinical and Molecular Studies in Families with Corneal Dystrophy$6,566
N01 · FY2010 · EY · contact PI
Clinical and Molecular Studies in Families of Congenital / Hereditary Cataracts$6,566
N01 · FY2010 · EY · contact PI
Trial of Cysteamine in Treatment of Corneal Cystine Accumulation in Cystinosis$6,566
N01 · FY2010 · EY · contact PI
Internal Monitoring of Eye Movement in Schizophrenia$6,566
N01 · FY2010 · EY · contact PI
EyeGENE: Creation of DNA Repository for Inherited Ophthalmic Diseases$674,691
N01 · FY2009 · EY · contact PI
Age-Related Macular Degeneration: A Genetic Epidemiology Study in the Amish$200,000
N01 · FY2009 · EY · contact PI
Subconjunctival Sirolimus in the Treatment of AMD Bilateral Geographic Atrophy$154,158
N01 · FY2009 · EY · contact PI
High Speed Angiography: Induction/PRN Regimen of Intravitreal Ranibizumab for AMD$143,153
N01 · FY2009 · EY · contact PI
Pilot: Sunitinib Malate for Advance Ocular Disease of Von Hippel-Lindau Syndrome$142,012
N01 · FY2009 · EY · contact PI
Treatment of Choroidal Subretinal Neovascularization against Immune Response$139,327
N01 · FY2009 · EY · contact PI
Laboratory of Immunology/National Eye Institute Repository$139,327
N01 · FY2009 · EY · contact PI
Immunopathology and Molecular Pathology of Ocular Diseases in Humans$139,327
N01 · FY2009 · EY · contact PI
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol$139,327
N01 · FY2009 · EY · contact PI
Study of Association of Serum Factors with Diabetic Retinopathy$139,327
N01 · FY2009 · EY · contact PI
Family Studies of Uveal Coloboma$139,327
N01 · FY2009 · EY · contact PI
Visual Motor Coordination$139,327
N01 · FY2009 · EY · contact PI
Evaluation of Single Nucleotide Polymorphism (SNP) in AMD Patients$139,327
N01 · FY2009 · EY · contact PI
Eval. of Immune Response to Antigens in NonInfectious Ocular Inflammatory Disease$139,327
N01 · FY2009 · EY · contact PI
A Phase II Study of OT-551 Antioxidant Eye Drop$139,327
N01 · FY2009 · EY · contact PI
Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease$139,327
N01 · FY2009 · EY · contact PI
Epigenetics, Molecular Genetics, and Biomarkers of Inflammatory Ocular Diseases$139,327
N01 · FY2009 · EY · contact PI
X Chr. Karyotype & Sex Hormones in Turner Syndrome & Premature Ovarian failure$139,327
N01 · FY2009 · EY · contact PI
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism$139,327
N01 · FY2009 · EY · contact PI
Clinical and Molecular Studies in Families with Glaucoma$139,327
N01 · FY2009 · EY · contact PI
Clinical and Molecular Studies in Families with Myopia and Related Diseases$139,327
N01 · FY2009 · EY · contact PI
Molecular Genetics of Retinal Degenerations$139,327
N01 · FY2009 · EY · contact PI
Natural History and Genetic Studies of Usher Syndrome$139,327
N01 · FY2009 · EY · contact PI
Clinical and Molecular Studies in Families with Corneal Dystrophy$139,327
N01 · FY2009 · EY · contact PI
Clinical and Molecular Studies in Families of Congenital / Hereditary Cataracts$139,327
N01 · FY2009 · EY · contact PI
A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 PUFA in AMD$139,327
N01 · FY2009 · EY · contact PI
Trial of Cysteamine in Treatment of Corneal Cystine Accumulation in Cystinosis$139,327
N01 · FY2009 · EY · contact PI
Study of Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema$131,072
N01 · FY2009 · EY · contact PI
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies$118,387
N01 · FY2009 · EY · contact PI
Intravitreal Inj of Ranibizumab for Macular Telangiectasia w/o Neovascularization$98,960
N01 · FY2009 · EY · contact PI
Intravitreal Inj of Ranibizumab for Macular Telangiectasia w Neovascularization$92,154
N01 · FY2009 · EY · contact PI
Age-Related Eye Disease Study (AREDS) Follow-Up$81,102
N01 · FY2009 · EY · contact PI
Pilot: Finasteride Treatment for Chronic Central Serous Chorioretinopathy$79,664
N01 · FY2009 · EY · contact PI
Subconjunctival Sirolimus for Treatment of Autoimmune Active Anterior Uveitis$68,934
N01 · FY2009 · EY · contact PI
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY$62,931
N01 · FY2009 · EY · contact PI
Treatment of Uveitic Cystoid Macular Edema with Topical Interferon Gamma$55,564
N01 · FY2009 · EY · contact PI
Screening Study for the Evaluation and Diagnosis of Research Participants$50,000
N01 · FY2009 · EY · contact PI
Evaluation and Treatment of Research Participants with Ocular Diseases$50,000
N01 · FY2009 · EY · contact PI
Phase I Clinical Trial: Safety of Subconjunctival Cyclosporine Implant for GVHD$31,530
N01 · FY2009 · EY · contact PI
Pilot: Computer Administration of Vision Targeted Quality of Life Instruments$30,925
N01 · FY2009 · EY · contact PI